Strategies for Prolonged Therapy in Patients With Advanced Non-Small-Cell Lung CancerFIDIAS, Panos; NOVELLO, Silvia.Journal of clinical oncology. 2010, Vol 28, Num 34, pp 5116-5123, issn 0732-183X, 8 p.Article

Emerging New Agents for the Management of Patients with Non-Small Cell Lung CancerCAPELLETTO, Enrica; NOVELLO, Silvia.Drugs (Basel). 2012, Vol 72, pp 37-52, issn 0012-6667, 16 p., SUP1Article

Efficacy of neoadjuvant strategies with gemcitabine and other chemotherapy in resectable non-small cell lung cancer: A combined modality approachSCAGLIOTTI, Giorgio V; NOVELLO, Silvia.Seminars in oncology. 2003, Vol 30, Num 4, pp 13-18, issn 0093-7754, 6 p., SUP10Article

Ongoing/planned studies in france stage I-II NSCLCNOVELLO, Silvia; LE CHEVALIER, Thierry.Lung cancer. 2001, Vol 34, pp S59-S61, issn 0169-5002, SUP3Conference Paper

The emerging role of MET/HGF inhibitors in oncologySCAGLIOTTI, Giorgio V; NOVELLO, Silvia; VON PAWEL, Joachim et al.Cancer treatment reviews. 2013, Vol 39, Num 7, pp 793-801, issn 0305-7372, 9 p.Article

Adjuvant chemotherapy after complete resection for early stage NSCLCSCAGLIOTTI, Giorgio; NOVELLO, Silvia.Lung cancer. 2003, Vol 42, pp S47-S51, issn 0169-5002, SUP1Conference Paper

European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancerNOVELLO, Silvia; LE CHEVALIER, Thierry.Seminars in oncology. 2001, Vol 28, Num 4, pp 3-9, issn 0093-7754, SUP14Article

Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the LungMONICA, Valentina; SCAGLIOTTI, Giorgio V; CEPPI, Paolo et al.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7547-7552, issn 1078-0432, 6 p.Article

Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancerPOSTMUS, Pieter E; ROCMANS, Pierre; PIRKER, Robert et al.Lung cancer. 2003, Vol 42, pp S3-S6, issn 0169-5002, SUP1Conference Paper

Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and ^mTC-albumin microcolloid techniqueCATTEL, Luigi; BUFFA, Elena; DE SIMONE, Michele et al.Anticancer research. 2001, Vol 21, Num 3C, pp 2243-2248, issn 0250-7005Article

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumorsINFANTE, Jeffrey R; NOVELLO, Silvia; OTTESEN, Lone H et al.Investigational new drugs. 2013, Vol 31, Num 4, pp 927-936, issn 0167-6997, 10 p.Article

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy : A prognostic analysis of the multicenter Italian lung cancer in the elderly studyMAIONE, Paolo; PERRONE, Francesco; BERTETTO, Oscar et al.Journal of clinical oncology. 2005, Vol 23, Num 28, pp 6865-6872, issn 0732-183X, 8 p.Article

Gemcitabine and vinorelbine in recurrent head and neck cancer: Pharmacokinetic and clinical resultsAIROLDI, Mario; CATTEL, Luigi; CORTESINA, Giorgio et al.Anticancer research. 2003, Vol 23, Num 3C, pp 2845-2852, issn 0250-7005, 8 p.Article

HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma: Impact on long-term survivalSELVAGGI, Giovanni; SCAGLIOTTI, Giorgio V; TORRI, Valter et al.Cancer. 2002, Vol 94, Num 10, pp 2669-2674, issn 0008-543XArticle

Time to Activate Lung Cancer Clinical Trials and Patient Enrollment: A Representative Comparison Study Between Two Academic Centers Across the AtlanticWANG-GILLAM, Andrea; WILLIAMS, Kristina; NOVELLO, Silvia et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3803-3807, issn 0732-183X, 5 p.Article

Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non―Small-Cell Lung Cancer: A Randomized, Controlled Phase III TrialRAMLAU, Rodryg; GORBUNOVA, Vera; REY, Augustin et al.Journal of clinical oncology. 2012, Vol 30, Num 29, pp 3640-3647, issn 0732-183X, 8 p.Article

Pulmonary Toxicity Related to Systemic Treatment of Nonsmall Cell Lung CancerDE SANCTIS, Alice; TAILLADE, Laurent; VIGNOT, Stephane et al.Cancer. 2011, Vol 117, Num 14, pp 3069-3080, issn 0008-543X, 12 p.Article

Phase II Study of the Anti―Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non―Small-Cell Lung CancerKARP, Daniel D; PAZ-ARES, Luis G; JOHNSON, Faye M et al.Journal of clinical oncology. 2009, Vol 27, Num 15, pp 2516-2522, issn 0732-183X, 7 p.Article

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: A multicenter, randomized, phase II trialSCAGLIOTTI, Giorgio V; KORTSIK, Cornelius; NOVELLO, Silvia et al.Clinical cancer research. 2005, Vol 11, Num 2, pp 690-696, issn 1078-0432, 7 p., 1Article

The biology of epidermal growth factor receptor in lung cancerSCAGLIOTTI, Giorgio V; SELVAGGI, Giovanni; NOVELLO, Silvia et al.Clinical cancer research. 2004, Vol 10, Num 12, pp 4227s-4232s, issn 1078-0432, 2Conference Paper

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients : Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trialGRIDELLI, Cesare; CIGOLARI, Silvio; NOVELLO, Silvia et al.Lung cancer. 2001, Vol 31, Num 2-3, pp 277-284, issn 0169-5002Article

Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung CancerLANGER, Corey J; NOVELLO, Silvia; KEUNCHIL PARK et al.Journal of clinical oncology. 2014, Vol 32, Num 19, pp 2059-2066, issn 0732-183X, 8 p.Article

Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendationsPINTO, Carmine; NOVELLO, Silvia; MIRABELLI, Dario et al.Cancer treatment reviews. 2013, Vol 39, Num 4, pp 328-339, issn 0305-7372, 12 p.Article

Clinical meta-analyses of targeted therapies in adenocarcinomaBRIA, Emilio; BONOMI, Maria; PILOTTO, Sara et al.Targeted oncology. 2013, Vol 8, Num 1, pp 35-45, issn 1776-2596, 11 p.Article

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung CancerRAMALINGAM, Suresh S; SPIGEL, David R; LIAN LIU et al.Journal of clinical oncology. 2011, Vol 29, Num 34, pp 4574-4580, issn 0732-183X, 7 p.Article